SLC18A1 (solute carrier family 18 member A1) is also termed as vesicular monoamine transporter 1 (VMAT1). It is expressed in brain and in neurons of the peripheral nervous system, endocrine tissue and chromaffin cells. SLC18A1 is located in human chromosome 8p21.
Synonyms: CGAT; VAT1; VMAT1
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: SLC18A1 (solute carrier family 18 member A1) modulates monoamines, hence it is considered as a candidate gene for psychiatric disorders. It plays a key role in the transfer of dopamine, serotonin, adrenaline and noradrenaline from the cytoplasm to their storage vesicles in presynaptic terminals. SLC18A1 is linked with schizophrenia, bipolar disorders, anxiety and depression.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC